T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AEGN
601
DELISTED
Aegion Corp
AEGN
| $89.7M | 0.01% |
5,004,236
+585,619
| +13% | +$11.6M |
|
602
Steven Madden
SHOO
$3.46B
| $89.5M | 0.01% |
3,852,802
+549,456
| +17% | +$19M |
|
603
Simply Good Foods
SMPL
$989M
| $89M | 0.01% |
4,621,193
+52,104
| +1% | +$1.14M |
|
604
Hanover Insurance
THG
$7.77B
| $88.9M | 0.01% |
981,289
+5,692
| +0.6% | +$704K |
|
|
CVET
605
DELISTED
Covetrus, Inc. Common Stock
CVET
| $88.5M | 0.01% |
10,877,709
+5,336,300
| +96% | +$61M |
|
|
SWAV
606
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $88.4M | 0.01% |
2,664,973
-1,365,237
| -34% | -$54.2M |
|
607
Take-Two Interactive
TTWO
$45.2B
| $88.4M | 0.01% |
744,930
+12,053
| +2% | +$1.42M |
|
|
PPBI
608
DELISTED
Pacific Premier Bancorp
PPBI
| $87.3M | 0.01% |
4,635,238
+1,098,018
| +31% | +$29.2M |
|
|
SIVB
609
DELISTED
SVB Financial Group
SIVB
| $87.2M | 0.01% |
577,163
+15,466
| +3% | +$3.4M |
|
610
Analog Devices
ADI
$186B
| $87.1M | 0.01% |
971,589
+58,149
| +6% | +$6.36M |
|
|
EBSB
611
DELISTED
Meridian Bancorp, Inc.
EBSB
| $87M | 0.01% |
7,758,158
+18,479
| +0.2% | +$306K |
|
612
Fair Isaac
FICO
$24B
| $86.9M | 0.01% |
282,522
-56,301
| -17% | -$20.7M |
|
613
Kilroy Realty
KRC
$4.3B
| $86.8M | 0.01% |
1,362,924
-137,088
| -9% | -$10.4M |
|
614
Valmont Industries
VMI
$9.5B
| $86.3M | 0.01% |
814,510
-256,551
| -24% | -$33.3M |
|
615
Autodesk
ADSK
$54.5B
| $85.9M | 0.01% |
550,072
+1,622
| +0.3% | +$298K |
|
|
XIFR
616
XPLR Infrastructure LP
XIFR
$1.09B
| $85.7M | 0.01% |
1,993,560
+27,892
| +1% | +$1.48M |
|
|
SAGE
617
DELISTED
Sage Therapeutics
SAGE
| $85.1M | 0.01% |
2,964,308
-2,684,880
| -48% | -$155M |
|
618
Seacoast Banking Corp of Florida
SBCF
$3.48B
| $85M | 0.01% |
4,640,472
+83,874
| +2% | +$2.12M |
|
619
Takeda Pharmaceutical
TAK
$55.5B
| $84.5M | 0.01% |
5,567,466
+1,458,068
| +35% | +$26.4M |
|
620
Popular Inc
BPOP
$11.3B
| $84.5M | 0.01% |
2,413,802
+30,186
| +1% | +$1.49M |
|
621
WSFS Financial
WSFS
$4.17B
| $84.3M | 0.01% |
3,382,280
+312,615
| +10% | +$11.3M |
|
622
Tyler Technologies
TYL
$13.5B
| $84.2M | 0.01% |
284,072
-7,310
| -3% | -$2.27M |
|
623
NovoCure
NVCR
$2.02B
| $84.2M | 0.01% |
1,251,011
-79,626
| -6% | -$6.29M |
|
|
OPTU
624
Optimum Communications Inc
OPTU
$228M
| $84.2M | 0.01% |
3,777,999
-3,106,222
| -45% | -$81.1M |
|
625
PRA Group
PRAA
$762M
| $84.2M | 0.01% |
3,037,826
+270,372
| +10% | +$9.42M |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.